Delivery Order SPE2DB24D1021-SPE2DB25FEZKY
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $16,372.29 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, awarded on August 4, 2025, represents a non-competitive set-aside contract and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $27,419.98 and an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- The Defense Logistics Agency awarded a delivery order valued at $12,030.67 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets (quantity: 30 units). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) valued at $8,457.03. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. As a child contract under a larger...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZKYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $16,037.51. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that serves as the primary mechanism for federal pharmaceutical procurement across military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal procurement relationships with the Defense Logistics Agency and serves critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill competitive federal medical supply contracts across a diverse portfolio of pharmaceutical products—including specialty medications, vaccines, and medical devices—positions it as a key vendor within the DLA's Troop Support Medical supply chain. This delivery order for DESCOVY, an antiretroviral medication, reflects the company's continued role in supplying essential pharmaceuticals to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 8/7/25 |